Fungal Infection – IV

  • AmBisome 2017 report

    AmBisome 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2017 report

    Cresemba 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2017 report

    Noxafil 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • AmBisome 2016 report

    AmBisome 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2016 report

    Cresemba 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2016 report

    Noxafil 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • AmBisome 2015 report

    AmBisome 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Cresemba 2015 report

    Cresemba 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Noxafil 2015 report

    Noxafil 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • AmBisome 2014 report

    AmBisome 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 29 Pages The 5 Key Questions Addressed by this...

  • Noxafil 2014 report

    Noxafil 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...